As shown in Fig. 1a and Table 1, out of 20 evaluable patients who provided biopsies, 16 patients (80%) had high CD36 levels in the tumor cells, and 4 patients (20%) had medium CD36 levels in the tumor cells. Here, CD36 is linked to neoplasm.